Kenvue (KUVE) has named Kirk Perry, a current director, as its interim CEO, effective immediately. Concurrently, Thibaut Mongon has left the company and resigned from the Kenvue Board. Perry, who ...

Kenvue Inc. (NYSE:KVUE) is one of the 10 Stocks with Huge Catalysts on the Horizon. The company names an interim CEO and ...

American consumer health company Kenvue's Board of Directors announced new actions to unlock shareholder value and an interim ...

Kirk Perry has been named interim CEO, effective immediately, as the board conducts a search for Mongon's permanent successor, the company said Monday. Perry is a current Kenvue director and seasoned ...

(RTTNews) - Consumer health company Kenvue, Inc. (KVUE) announced Monday that its Board of Directors has appointed Kirk Perry as Interim Chief Executive Officer, effective immediately. Thibaut ...

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the company is considering simplifying its portfolio amid a recent sales slump.

Kenvue appoints Kirk Perry as interim CEO after Thibaut Mongon's exit and launches strategic review to simplify operations.

Kenvue says that CEO Thibaut Mongon is departing as the maker of Listerine and Band-Aid brands continues with a strategic review of the company. Kenvue used to be a part of Johnson & Johnson.

Kenvue (KVUE) said on Monday that CEO Thibaut Mongon has left the company and stepped down from its board, with Kirk Perry succeeding him as the interim chief executive officer, effective immediately.

Por MICHELLE CHAPMANEl CEO de Kenvue dejará su cargo mientras el fabricante de las marcas Listerine y Band-Aid continúa con una revisión estratégica de sus negocios. Thibaut ...

Kenvue named director Kirk Perry as interim CEO, while Mongon also stepped down from the board. Perry, who worked at Procter & Gamble (PG.N) for 23 years, most recently served as CEO of technology ...